✦ LIBER ✦

Clinical Efficacy and Safety of Successful Longterm Urate Lowering with Febuxostat or Allopurinol in Subjects with Gout

✍ Scribed by BECKER, M. A.; SCHUMACHER, H. R.; MacDONALD, P. A.; LLOYD, E.; LADEMACHER, C.

Book ID: 111982025
Publisher: Journal of Rheumatology Publishing Company
Year: 2009
Tongue: English
Weight: 535 KB
Volume: 36
Category: Article
ISSN: 0315-162X
DOI: 10.3899/jrheum.080814

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Women with gout: Efficacy and safety of

Women with gout: Efficacy and safety of urate-lowering with febuxostat and allopurinol

✍ Saima Chohan; Michael A. Becker; Patricia A. MacDonald; Solomon Chefo; Robert L. 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 113 KB

Safety and Efficacy of Febuxostat Treatm

Safety and Efficacy of Febuxostat Treatment in Subjects with Gout and Severe Allopurinol Adverse Reactions

✍ Chohan, Saima (author) 📂 Article 📅 2011 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 320 KB

Safety and Efficacy of Febuxostat Treatm

Safety and Efficacy of Febuxostat Treatment in Subjects with Gout and Severe Allopurinol Adverse Reactions

✍ Chohan, Saima (author) 📂 Article 📅 2011 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 320 KB

Effects of febuxostat versus allopurinol

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial

✍ Schumacher, H. RALPH ;Becker, Michael A. ;Wortmann, Robert L. ;MacDonald, Patric 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

## Abstract ## Objective To compare the urate‐lowering efficacy and safety of febuxostat, allopurinol, and placebo in a large group of subjects with hyperuricemia and gout, including persons with impaired renal function. ## Methods Subjects (n = 1,072) with hyperuricemia (serum urate level ≥8.0

Investigation of the clinical efficacy a

Investigation of the clinical efficacy and safety of pregabalin alone or combined with tolterodine in female subjects with idiopathic overactive bladder

✍ Josef Marencak; Nandini H. Cossons; Amanda Darekar; Ian W. Mills 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 343 KB

Febuxostat, a novel nonpurine selective

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: A twenty-eight–day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout

✍ Michael A. Becker; H. Ralph Schumacher Jr.; Robert L. Wortmann; Patricia A. MacD 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 3 views

## Abstract ## Objective Gout affects ∼1–2% of the American population. Current options for treating hyperuricemia in chronic gout are limited. The purpose of this study was to assess the safety and efficacy of febuxostat, a nonpurine selective inhibitor of xanthine oxidase, in establishing normal